Participated · Equity · May 2026

P2 Science develops proprietary, nature-inspired chemical processes to produce renewable specialty ingredients with a focus on performance and sustainability at scale. The company has launched beauty ingredients including Citrolatum® P, a 1:1 plant-based petrolatum replacement, and CitroComplex® Nourish, a natural oil blend for skin and hair, and entered a strategic partnership with Algenesis to develop 100% biobased, biodegradable polyurethanes. P2 has been recognized by Fast Company in 2025 and 2026 and was selected for L'Oréal's L'AcceleratOR sustainable innovation accelerator. It recently received $2.8 million in non-dilutive ARPA-E funding to accelerate catalyst innovation via AI-enhanced autonomous labs. The company plans to use its new equity financing to scale commercial production in beauty and expand its platform into adjacent markets such as aroma technologies, performance polymers, home care, coatings, and crop care. P2 was co-founded by Professor Paul Anastas and Dr. Patrick Foley at Yale's Center for Green Chemistry and Green Engineering and is based in Woodbridge, Connecticut.

Participated · Series C · Jun 2022

Evolved By Nature develops a proprietary library of Activated Silk™ molecules derived from natural silk protein to protect, repair, and enhance the barrier function of surfaces. Its Activated Silk biotechnology is positioned to enable next-generation products across textiles, personal care, aesthetic and medical treatments, therapeutics and more. The company reports commercial adoption of its biodegradable, high-performance finishes by fashion brands including Anya Hindmarch, nylon mills such as Alpine Creations and Apex Holdings, and leather tanneries including Richard Hoffmans GmbH & Co. KG, Cyclica Srl and Curtidos Bengala. The financing will support commercialization of the Activated Silk technology platform and the company’s goal of reducing dependence on synthetics and fossil-fuel derivatives. The round coincides with the launch of a full-scale manufacturing facility in Walpole, Massachusetts, which will ramp production to 900 metric tons of Activated Silk™ per year. Evolved By Nature was founded in 2013 by Dr. Greg Altman (CEO) and Dr. Rebecca Lacouture (President, COO) and is based in Boston, Massachusetts.

Participated · Series A · Oct 2021

Arcaea develops cell-grown cosmetic ingredients using Ginkgo Bioworks’ platform to program cells to produce functional materials such as keratin and sun-protection components. The company plans to grow keratin in bioreactors without animal sourcing, enabling local production and shorter supply chains that reduce emissions. Arcaea aims to create entirely new, engineered ingredients by reprogramming proteins to deliver specific effects (for example, altering hair structure to curl or straighten). Founder and CEO Yasmina Aganovich previously founded Mother Dirt in 2015 and left in 2019 to become an entrepreneur-in-residence at Ginkgo, where she established Arcaea. The startup intends to supply its ingredients to cosmetic brands and also plans to release its own product line. Management says it will take several years to bring new products to market, is investing heavily in R&D now, and expects lab-grown ingredients ultimately to be priced comparably to existing market alternatives. Financially, Arcaea has secured $78 million from major beauty players including Chanel, perfumery company Givaudan, and Viking Global Investors.

Participated · Equity · Dec 2019

Sulapac develops a patented biobased and biodegradable material designed to replace conventional plastics. Its materials are suitable for chemical recycling and incorporate recycled inputs. Sulapac sells material produced by subcontractors and runs joint development projects with global brands such as Chanel and Shiseido; its products are used in food service outlets like Carrefour and by brands such as Four Seasons. The company plans to scale on global markets and establish small-scale manufacturing capabilities to accelerate R&D and produce commercial small-scale batches of new sustainable materials. Sulapac received a loan from Nefco to support those plans; the amount was not disclosed. Sulapac develops a microplastic-free material intended to replace conventional plastics. Its product lineup includes what the company describes as the world’s most sustainable mass-producible straw and a Universal Material for Injection Molding, with plans to create a flexible version. The company aims to scale up material production and internationalise its business. To support that, Sulapac has raised €15 million to accelerate scaling and continued product development. New investors and advisors are intended to bring long-term support, sustainability commitment, and international growth expertise to the company. Management changes include the appointment of Jukka Moisio as chair and new advisors such as Sophia Bendz and Charli Kumar to bolster brand and market expansion efforts.